Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The PROPER Study: A 48-Week, Pan-European, Real-World Study of Biosimilar SB5 Following Transition from Reference Adalimumab in Patients with Immune-Mediated Inflammatory Disease.
Müller-Ladner U, Dignass A, Gaffney K, Jadon D, Matucci-Cerinic M, Lobaton T, Carron P, Gisbert JP, Pande I, Utzinger M, Addison J. Müller-Ladner U, et al. Among authors: lobaton t. BioDrugs. 2023 Nov;37(6):873-889. doi: 10.1007/s40259-023-00616-3. Epub 2023 Aug 26. BioDrugs. 2023. PMID: 37632666 Free PMC article. Clinical Trial.
Gut Inflammation in Axial Spondyloarthritis Patients is Characterized by a Marked Type 17 Skewed Mucosal Innate-like T Cell Signature.
Mortier C, Quintelier K, De Craemer AS, Renson T, Deroo L, Dumas E, Verheugen E, Coudenys J, Decruy T, Lukasik Z, Van Gassen S, Saeys Y, Hoorens A, Lobatón T, Van den Bosch F, Van de Wiele T, Venken K, Elewaut D. Mortier C, et al. Among authors: lobaton t. Arthritis Rheumatol. 2023 Nov;75(11):1969-1982. doi: 10.1002/art.42627. Epub 2023 Oct 4. Arthritis Rheumatol. 2023. PMID: 37293832
Distinct immune modulatory roles of regulatory T cells in gut versus joint inflammation in TNF-driven spondyloarthritis.
Venken K, Jarlborg M, Decruy T, Mortier C, Vlieghe C, Gilis E, De Craemer AS, Coudenys J, Cambré I, Fleury D, Klimowicz A, Van den Bosch F, Hoorens A, Lobaton T, de Roock S, Sparwasser T, Nabozny G, Jacques P, Elewaut D. Venken K, et al. Among authors: lobaton t. Ann Rheum Dis. 2023 Aug;82(8):1076-1090. doi: 10.1136/ard-2022-223757. Epub 2023 May 17. Ann Rheum Dis. 2023. PMID: 37197892
Successful treatment of ulcerative colitis with anakinra: a case report.
Truyens M, Hoste L, Geldof J, Hoorens A, Haerynck F, Huis In 't Veld D, Lobatón T. Truyens M, et al. Among authors: lobaton t. Acta Gastroenterol Belg. 2023 Oct-Dec;86(4):573-576. doi: 10.51821/86.4.11246. Acta Gastroenterol Belg. 2023. PMID: 38240554 Free article. No abstract available.
Editorial: Current trends and future management of IBD.
Estevinho MM, Lobatón T, Noor N, Rodríguez-Lago I. Estevinho MM, et al. Among authors: lobaton t. Front Med (Lausanne). 2023 Apr 13;10:1195201. doi: 10.3389/fmed.2023.1195201. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37122323 Free PMC article. No abstract available.
Position statement on the management of the immune checkpoint inhibitor-induced colitis via multidisciplinary modified Delphi consensus.
Desmedt V, Jauregui-Amezaga A, Fierens L, Aspeslagh S, Dekervel J, Wauters E, Peeters M, Sabino J, Crapé L, Somers M, Hoorens A, Dutré J, Lobatón T; for BIRD (Belgian IBD Research and Development); Belgian Society of Medical Oncology (BSMO); Belgian group of Digestive Oncology (BGDO); BeRS (Belgian Respiratory Society); participants of the collaborator group in the modified Delphi consensus for the Position Statement on the management of the immune checkpoint inhibitor induced colitis. Desmedt V, et al. Among authors: lobaton t. Eur J Cancer. 2023 Jul;187:36-57. doi: 10.1016/j.ejca.2023.03.025. Epub 2023 Mar 25. Eur J Cancer. 2023. PMID: 37116287 Review.
Rates of Adverse Events in Patients With Ulcerative Colitis Undergoing Colectomy During Treatment With Tofacitinib vs Biologics: A Multicenter Observational Study.
Dragoni G, Innocenti T, Amiot A, Castiglione F, Melotti L, Festa S, Savarino EV, Truyens M, Argyriou K, Noviello D, Molnar T, Bouillon V, Bezzio C, Eder P, Fernandes S, Kagramanova A, Armuzzi A, Oliveira R, Viola A, Ribaldone DG, Drygiannakis I, Viganò C, Calella F, Gravina AG, Pugliese D, Chaparro M, Ellul P, Vieujean S, Milla M, Caprioli F; “TOFA-poSTOP” Study Group. Dragoni G, et al. Am J Gastroenterol. 2024 Mar 19. doi: 10.14309/ajg.0000000000002676. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38305302
Safety and Effectiveness of Vedolizumab and Ustekinumab in Elderly Patients with Inflammatory Bowel Disease: A Real-Life Multicentric Cohort Study.
Holvoet T, Truyens M, De Galan C, Peeters H, Gismero FM, Elorza A, Torres P, Vandermeulen L, Jauregui-Amezaga A, Ferreiro-Iglesias R, Zabana Y, Reverter LP, Geldof J, Lobatón T. Holvoet T, et al. Among authors: lobaton t. J Clin Med. 2024 Jan 9;13(2):365. doi: 10.3390/jcm13020365. J Clin Med. 2024. PMID: 38256499 Free PMC article.
Prophylactic versus endoscopy-driven treatment of Crohn's postoperative recurrence: A retrospective, multicentric European study (PORCSE study).
Geldof J, Truyens M, Hanssens M, Van Gucht E, Holvoet T, Elorza A, Bouillon V, Barros S, Martins V, Argyriou K, Potamianos S, Diculescu M, Stroie T, Bossuyt P, Moens A, Theodoraki E, Koutroubakis IE, Pedro J, Fernandes S, Nikolaou P, Karmiris K, Baert FJ, Ferreiro-Iglesias R, Peeters H, Claeys S, Casanova MJ, Eder P, Porter RJ, Arnott I, Karakan T, Mesonero F, Revés J, Van Dyck E, Jauregui-Amezaga A, Mañosa M, Rivière P, Marquez Mosquera L, Portela F, Pimentel R, Lobaton T. Geldof J, et al. Among authors: lobaton t. J Crohns Colitis. 2024 Jan 19:jjae011. doi: 10.1093/ecco-jcc/jjae011. Online ahead of print. J Crohns Colitis. 2024. PMID: 38243807
68 results